UK, MiLife is Renamed to Imperative Health and Raises $4M

MiLife, a London, Uk-based spin-out from Unilever Corporate Research (UCR) focused on providing health management technology solutions to address high-risk health conditions, including diabetes, high blood pressure, obesity, and raised cholesterol, has completed an additional funding of $4m.
The new capital, which was provided by Unilever Ventures and New Venture Partners, will be used to accelerate its development and growth.
In addition, to reflect a shift in strategic direction, the company has changed its name to Imperative Health and its focus to managing health risks associated with diabetes, high blood pressure, obesity, and raised cholesterol.
The new strategy was created and will be implemented by the new executive team.

Created by Unilever Ventures in 2008 via a spin-out of the Unilever technology, the company was initially focused on personalised weight management.
In early 2009, Imperative appointed Chris Jessop as Chairman and CEO.
Mr. Jessop strengthened the team by recruiting Dr. Sabine Donnai, a leading UK authority on preventative medicine, as director and Chief Medical Officer; and Mr. Clive Pinder, an international healthcare entrepreneur as non-executive director.
Imperative’s service consists of a wireless activity monitor, a heart-rate monitor, a scale, an online coaching system, and telephone and e-mail access to health experts. The solution has been validated through clinical trials for its level of user engagement and effectiveness.

Join the discussion